Genomic surveillance of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has varied across countries. England's increased…
View More COVID-19 CG tracks local SARS-CoV-2 mutations by geographical location
Home » antibodies »
Full characterization of mammalian-produced SARS-CoV-2 receptor binding domains
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) interacts with angiotensin-converting enzyme 2 (ACE2) receptors on…
View More Full characterization of mammalian-produced SARS-CoV-2 receptor binding domains
Detection of emerging SARS-CoV-2 variant in New York
Researchers at the California Institute of Technology in Pasadena have developed a software tool called…
View More Detection of emerging SARS-CoV-2 variant in New York
Enzyme-linked Immunosorbent Assay (ELISA): Methodology
Enzyme-Linked Immunosorbent Assay (ELISA) is an immunological technique used for detecting and measuring specific proteins,…
View More Enzyme-linked Immunosorbent Assay (ELISA): Methodology
Tripacel
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TRIPACEL® …
View More Tripacel
Nearly pain-free microneedle patch can test for antibodies and more in the fluid between cells
Blood draws are no fun. They hurt. Veins can burst, or even roll—like they’re trying…
View More Nearly pain-free microneedle patch can test for antibodies and more in the fluid between cells
Understanding how to improve antibodies targeting treatment of cancer
Scientists at the University of Southampton’s Centre for Cancer Immunology have gained new insight into…
View More Understanding how to improve antibodies targeting treatment of cancer
New serological assay provides rapid, accurate testing for SARS-CoV-2 antibodies
Researchers at UC Santa Cruz have developed a novel serological assay for the detection of…
View More New serological assay provides rapid, accurate testing for SARS-CoV-2 antibodies
Antibodies to SARS-CoV-2 are detected up to 3 months after infection
A new study in health care workers led by the Barcelona Institute for Global Health…
View More Antibodies to SARS-CoV-2 are detected up to 3 months after infection
Harvard study finds COVID-19 antibodies could last up to four months
Harvard study finds patients who survive severe COVID-19 infections have antibodies for up to four…
View More Harvard study finds COVID-19 antibodies could last up to four months